...mos.) (P= .006). Combined analysis of pretreatment serum EGFR and HER-2 yielded no additional predictive information for...
...mos (0.1 - 48.16) there was no difference in the OS, one-year survival, OR and TTP. However, statistically significant d...
...mos) (0.5-9 mos). The median age is 51 yrs (28-76 yrs). Nineteen patients (53%) had hemoglobin <12 g/dl and 13 (35%) had...
...mos post NMT (range, 7+ to 45+ mos) (P = 0.001).,These data suggest that NMT may overcome the negative prognostic impact...
...mos) (.8-41.5). There was a trend towards improved survival with a negative CTD2 (p=.07). Besides known D2 survival pred...
...mos (3-18). Soft tissue metastases were present in 6 pts (46%) and bone metastases in 13 pts (100%). Thirteen pts are ev...
...most commonly used regimen of P+C to identify the combination associated with the best therapeutic index. We are now abl...
...mos. Pharmacokinetics revealed targeted S concentrations of ≥ 10 μM maintained in 87% and ≤ 50 μM maintained in all of t...
...MoS/PtNPs/SWCNT paper with an ultralow onset potential of -35 mV, a Tafel slope of 39.6 mV per decade and over 60 h of e...
...MoS sheets (named as MoS scrolls). A phase incorporated structure for MoS nanoscrolls containing the maximum concentrati...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269